XTL BIOPHARMACEUTICALS LTD (XTLB) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: June 30, 2026

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 7.36% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

950M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

XTLB currently has 946M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 7.36% over the past 2 years.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
Jun 30, 2026	20-F filing \| 946.2M shares outstanding	950M
Apr 30, 2025	20-F filing \| 881.4M shares outstanding	880M
Apr 30, 2024	20-F filing \| 544.9M shares outstanding	540M
Mar 22, 2023	20-F filing \| 544.9M shares outstanding	540M
Mar 30, 2022	20-F filing \| 544.9M shares outstanding	540M
Jun 02, 2021	POS AM filing: This is a filing for ADSs offered representing ordinary shares issuable upon exercise of warrants from previous private placements.	730M
Mar 15, 2021	20-F filing \| 514.2M shares outstanding	510M
Mar 12, 2020	20-F filing \| 514.2M shares outstanding	510M

Back to XTLB Details